These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29191711)

  • 1. Analyzing test batteries in animal models of psychopathology with multivariate analysis of variance (MANOVA): One possible approach to increase external validity.
    Stukalin Y; Einat H
    Pharmacol Biochem Behav; 2019 Mar; 178():51-55. PubMed ID: 29191711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the atypical antipsychotic asenapine in a strain-specific battery of tests for mania-like behaviors.
    Ene HM; Kara NZ; Einat H
    Behav Pharmacol; 2015 Jun; 26(4):331-7. PubMed ID: 25590966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of repeated asenapine in a battery of tests for anxiety-like behaviours in mice.
    Ene HM; Kara NZ; Barak N; Reshef Ben-Mordechai T; Einat H
    Acta Neuropsychiatr; 2016 Apr; 28(2):85-91. PubMed ID: 26357996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring test batteries for depression- and anxiety-like behaviours in female and male ICR and black Swiss mice.
    Kazavchinsky L; Dahan S; Einat H
    Acta Neuropsychiatr; 2020 Dec; 32(6):293-302. PubMed ID: 32378506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
    Szegedi A; Calabrese JR; Stet L; Mackle M; Zhao J; Panagides J;
    J Clin Psychopharmacol; 2012 Feb; 32(1):46-55. PubMed ID: 22198448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice.
    Einat H
    Pharmacol Rep; 2014 Aug; 66(4):722-5. PubMed ID: 24948079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder.
    Dencker D; Husum H
    Behav Brain Res; 2010 Feb; 207(1):78-83. PubMed ID: 19815032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Criteria defining antimanic drugs (psychopharmacological specificity and/or nonspecificity?)].
    Azorin JM
    Encephale; 2003; 29(1):59-67. PubMed ID: 12640328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series.
    Dell'Osso B; Cremaschi L; Palazzo MC; Spagnolin G; Cattaneo A; Grancini B; Maggi M; Altamura AC
    Expert Opin Drug Saf; 2014 Sep; 13(9):1199-208. PubMed ID: 25084462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania.
    Flaisher-Grinberg S; Overgaard S; Einat H
    J Neurosci Methods; 2009 Feb; 177(1):44-50. PubMed ID: 18930764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features.
    van Enkhuizen J; Milienne-Petiot M; Geyer MA; Young JW
    Psychopharmacology (Berl); 2015 Sep; 232(18):3455-67. PubMed ID: 26141192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial effects of the AMPAkine CX717 in a strain specific battery of tests for manic-like behavior in black Swiss mice.
    Kara NZ; Flaisher-Grinberg S; Einat H
    Pharmacol Rep; 2015 Oct; 67(5):928-33. PubMed ID: 26398387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questioning the predictive validity of the amphetamine-induced hyperactivity model for screening mood stabilizing drugs.
    Lan A; Einat H
    Behav Brain Res; 2019 Apr; 362():109-113. PubMed ID: 30630015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NO-sGC-cGMP signaling influence the anxiolytic like effect of lithium in mice in light and dark box and elevated plus maze.
    Walia V; Garg C; Garg M
    Brain Res; 2019 Feb; 1704():114-126. PubMed ID: 30292770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the functions of lithium: the mood stabilizer.
    Shastry BS
    Bioessays; 1997 Mar; 19(3):199-200. PubMed ID: 9103188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: Possible role of antioxidant and neurotrophic mechanisms.
    de Queiroz AIG; Chaves Filho AJM; Araújo TDS; Lima CNC; Machado MJS; Carvalho AF; Vasconcelos SMM; de Lucena DF; Quevedo J; Macedo D
    J Affect Disord; 2018 Jan; 225():40-51. PubMed ID: 28783519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lithium ion: a foundation for psychopharmacological specificity.
    Soares JC; Gershon S
    Neuropsychopharmacology; 1998 Sep; 19(3):167-82. PubMed ID: 9653704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.